Cipla settles patent litigation of Revlimid (lenalidomide) capsules with Celgene EP News Bureau Dec 11, 2020 Celgene has agreed to provide Cipla with a license to Celgene’s patents required to manufacture and sell certain volume-limited…
Cancer CART therapy: What are the benefits and stakes? EP News Bureau Jun 13, 2020 Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how…
Bristol-Myers Squibb Completes Acquisition of Celgene EP News Bureau Nov 21, 2019 Upon completion of the acquisition, pursuant to the terms of the merger agreement, Celgene became a wholly owned subsidiary of…